Aug 2026
Effect of Rivoceranib 200 mg Once Daily on the Pharmacokinetics of a Cocktail Probe Substrate of Cytochrome P450 Enzymes: A Phase I Trial in Healthy Volunteers
D. Nguyen, X. Wei, Xianzhang Meng et al.
· Clinical Pharmacokinetics · 0 citations